Correlation Between Dianthus Therapeutics and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Cardiff Oncology, you can compare the effects of market volatilities on Dianthus Therapeutics and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Cardiff Oncology.
Diversification Opportunities for Dianthus Therapeutics and Cardiff Oncology
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dianthus and Cardiff is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and Cardiff Oncology
Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 1.41 times more return on investment than Cardiff Oncology. However, Dianthus Therapeutics is 1.41 times more volatile than Cardiff Oncology. It trades about 0.24 of its potential returns per unit of risk. Cardiff Oncology is currently generating about -0.04 per unit of risk. If you would invest 2,096 in Dianthus Therapeutics on August 17, 2025 and sell it today you would earn a total of 1,989 from holding Dianthus Therapeutics or generate 94.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dianthus Therapeutics vs. Cardiff Oncology
Performance |
| Timeline |
| Dianthus Therapeutics |
| Cardiff Oncology |
Dianthus Therapeutics and Cardiff Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dianthus Therapeutics and Cardiff Oncology
The main advantage of trading using opposite Dianthus Therapeutics and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.| Dianthus Therapeutics vs. Enliven Therapeutics | Dianthus Therapeutics vs. Taysha Gene Therapies | Dianthus Therapeutics vs. Sana Biotechnology | Dianthus Therapeutics vs. ATAI Life Sciences |
| Cardiff Oncology vs. Applied Therapeutics | Cardiff Oncology vs. Corbus Pharmaceuticals Holding | Cardiff Oncology vs. Elicio Therapeutics | Cardiff Oncology vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |